An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure.
about
Benefits and harms of antidiabetic agents in patients with diabetes and heart failure: systematic reviewCongestive heart failure and diabetes mellitus: balancing glycemic control with heart failure improvementAfter avandia: the use of antidiabetic drugs in patients with heart failurePrognostic significance of hemoglobin A1c level in patients hospitalized with coronary artery disease. A systematic review and meta-analysisHeart Failure: a Major Cardiovascular Complication of Diabetes MellitusThe Use of SGLT-2 Inhibitors in Type 2 Diabetes and Heart FailureBurnt-out diabetes: impact of chronic kidney disease progression on the natural course of diabetes mellitus.Quality indicators and quality assessment in child healthGlucose, obesity, metabolic syndrome, and diabetes relevance to incidence of heart failure.Metformin therapy and outcomes in patients with advanced systolic heart failure and diabetes.Dose Modification of Antidiabetic Agents in Patients with Type 2 Diabetes Mellitus and Heart Failure.Relationship of glycated hemoglobin levels with myocardial injury following elective percutaneous coronary intervention in patients with type 2 diabetes mellitus.Treatment of type 2 diabetes and outcomes in patients with heart failure: a nested case-control study from the U.K. General Practice Research DatabaseThe effect of glycaemic control and glycaemic variability on mortality in patients hospitalized with congestive heart failure.Relation between hemoglobin a(1c) and outcomes in heart failure patients with and without diabetes mellitus.Association of HbA1c with hospitalization and mortality among patients with heart failure and diabetesA critical evaluation of glycated protein parameters in advanced nephropathy: a matter of life or death: A1C remains the gold standard outcome predictor in diabetic dialysis patients. Counterpoint.Glycemic variability during algorithmic titration of insulin among hospitalized patients with type 2 diabetes and heart failureThe U-shaped Relationship of Traditional Cardiovascular Risk Factors and Adverse Outcomes in Later Life.Comorbid Heart Failure and Renal Impairment: Epidemiology and Management.Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes.Glycosylated Haemoglobin (HbA1c) - A Marker of Circulating Lipids in Type 2 Diabetic Patients.Glycemic control and burnt-out diabetes in ESRD.Energetics and metabolism in the failing heart: important but poorly understood.Glycemic variability in hospitalized patients: choosing metrics while awaiting the evidence.Cardiogenic diabetes.Patient-level glucose reporting: averages, episodes, or something in between?Effect of tighter glycemic control on cardiac function, exercise capacity, and muscle strength in heart failure patients with type 2 diabetes: a randomized study.Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study.Intermediary variables and algorithm parameters for an electronic algorithm for intravenous insulin infusionHigher hemoglobin A1c levels are associated with impaired left ventricular diastolic function and higher incidence of adverse cardiac events in patients with nonischemic dilated cardiomyopathy.Oral glucose tolerance testing in an outpatient heart failure clinic reveals a high proportion of undiagnosed diabetic patients with an adverse prognosis.Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus.Assessing Risks of Glucose Lowering Therapy in Heart Failure: Should We Rely on Post-hoc Analyses?Routine use of HbA1c amongst inpatients hospitalised with decompensated heart failure and the association of dysglycaemia with outcomes
P2860
Q22242077-9E7AA49B-EDBC-4140-BD2E-9E4A4BFC8BF3Q27003819-1D9F2AB4-42C8-42E8-8B67-1FF07D2B92E7Q27021166-6AE4989E-A185-4A5B-9010-1D095BB88589Q27021243-30D626E0-52CE-4CE8-8237-06A1871C3EB0Q28066310-7CAE64B5-5B56-4742-85B7-FE596C8088E8Q28082343-AE6EBA84-4AD2-432D-B9A3-95ED641555A8Q30437526-404792B8-C641-4D32-9460-47549ED5B091Q33420659-71C4D51E-0CA1-435B-AD21-3C5EE0882D20Q33710663-6C7D9987-ECCE-4984-AB63-29F1388F7CF4Q33793434-BD022363-0C3A-483D-A1D4-1DC72691098AQ33815573-8A1A2FFD-2038-47B1-95FB-41944DA86227Q33837952-CC118331-AEE6-43E8-9AA2-46E9483DD723Q33873040-6E79C723-1D99-405A-9845-E8A112425490Q34680795-6AE168E7-49AF-4184-8362-9A6A3AF03657Q36007665-A6A32B06-92CD-47F2-A12D-9C6A9FB3B53EQ36024363-2D782698-8BB3-4F59-A96C-02FAE3C96312Q36047184-E7C4EC6B-2C96-4956-B025-4F8BEB33C621Q36421410-03DA235C-ADF8-4D18-810A-415823F725A5Q36467465-CA12A677-1E41-4FD2-8DD3-09F837780E2BQ36551356-87738CBA-B2AA-4733-A888-E62B9F720681Q37365538-89FA0E04-4E4D-4173-B878-FD045801008DQ37679034-B2A1295F-B56A-4A4A-BA90-15E33C4C6399Q37726287-4294F628-7C15-42AA-941E-28975F669D6EQ37746834-B31646BE-1ACF-43C5-BDC1-40E5EA429CE8Q38059650-92247117-851E-4BAA-871E-8689399298E3Q38156709-E1413BA4-C5E3-4924-A766-34C5C9533C3FQ39780640-D71745A8-2DA5-4F7B-A79E-3321E6C4B840Q39783916-E770ED64-D30B-4B80-8FC0-01079BA8AA1AQ41054147-81BD3B41-151C-4D5B-A2D1-04F349929865Q42599713-D34266FA-1614-49F7-8FD8-FAFE35674098Q48495099-622F4AF0-A92E-4E3B-AF02-6122E7F92341Q51384799-1C42FF6B-845C-48BF-98D4-2803B2C5323DQ55516149-883B37A7-8B27-4D53-AF76-7ED48C6DA343Q57629870-D45FBAB8-240F-4455-A43D-08D294E08FEAQ58755948-560EAFD5-478B-43FC-A887-BB39838EF706
P2860
An unexpected inverse relationship between HbA1c levels and mortality in patients with diabetes and advanced systolic heart failure.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
An unexpected inverse relation ...... vanced systolic heart failure.
@ast
An unexpected inverse relation ...... vanced systolic heart failure.
@en
An unexpected inverse relation ...... vanced systolic heart failure.
@nl
type
label
An unexpected inverse relation ...... vanced systolic heart failure.
@ast
An unexpected inverse relation ...... vanced systolic heart failure.
@en
An unexpected inverse relation ...... vanced systolic heart failure.
@nl
prefLabel
An unexpected inverse relation ...... vanced systolic heart failure.
@ast
An unexpected inverse relation ...... vanced systolic heart failure.
@en
An unexpected inverse relation ...... vanced systolic heart failure.
@nl
P921
P1476
An unexpected inverse relation ...... vanced systolic heart failure.
@en
P2093
Shervin Eshaghian
Tamara B Horwich
P356
10.1016/J.AHJ.2005.10.008
P407
P577
2006-01-01T00:00:00Z